2. Academic Validation
  3. Aeroplysinin-1, a Sponge-Derived Multi-Targeted Bioactive Marine Drug

Aeroplysinin-1, a Sponge-Derived Multi-Targeted Bioactive Marine Drug

  • Mar Drugs. 2015 Dec 22;14(1):1. doi: 10.3390/md14010001.
Javier A García-Vilas 1 2,  Beatriz Martínez-Poveda 3,  Ana R Quesada 4 5,  Miguel Ángel Medina 6 7
Affiliations

Affiliations

  • 1 Departamento de Biología Molecular y Bioquímica, Facultad de Ciencias, and IBIMA (Biomedical Research Institute of Málaga), Universidad de Málaga, Andalucía Tech, Málaga 29071, Spain. [email protected].
  • 2 CIBER de Enfermedades Raras (CIBERER), Málaga E-29071, Spain. [email protected].
  • 3 Departamento de Biología Molecular y Bioquímica, Facultad de Ciencias, and IBIMA (Biomedical Research Institute of Málaga), Universidad de Málaga, Andalucía Tech, Málaga 29071, Spain. [email protected].
  • 4 Departamento de Biología Molecular y Bioquímica, Facultad de Ciencias, and IBIMA (Biomedical Research Institute of Málaga), Universidad de Málaga, Andalucía Tech, Málaga 29071, Spain. [email protected].
  • 5 CIBER de Enfermedades Raras (CIBERER), Málaga E-29071, Spain. [email protected].
  • 6 Departamento de Biología Molecular y Bioquímica, Facultad de Ciencias, and IBIMA (Biomedical Research Institute of Málaga), Universidad de Málaga, Andalucía Tech, Málaga 29071, Spain. [email protected].
  • 7 CIBER de Enfermedades Raras (CIBERER), Málaga E-29071, Spain. [email protected].
PMID: 26703630 DOI: 10.3390/md14010001
Abstract

Organisms lacking external defense mechanisms have developed chemical defense strategies, particularly through the production of secondary metabolites with Antibiotic or repellent effects. Secondary metabolites from marine organisms have proven to be an exceptionally rich source of small molecules with pharmacological activities potentially beneficial to human health. (+)-Aeroplysinin-1 is a secondary metabolite isolated from marine sponges with a wide spectrum of bio-activities. (+)-Aeroplysinin-1 has potent Antibiotic effects on Gram-positive bacteria and several dinoflagellate microalgae causing toxic blooms. In preclinical studies, (+)-aeroplysinin-1 has been shown to have promising anti-inflammatory, anti-angiogenic and anti-tumor effects. Due to its versatility, (+)-aeroplysinin-1 might have a pharmaceutical interest for the treatment of different pathologies.

Keywords

(+)-aeroplysinin-1; angiogenesis; cancer; inflammation; marine drugs; sponges.

Figures
Products